Live tape
Top 8, mentions 7d10,987GOOGL2,090 mentions▲ +0.04SNDK1,553 mentions▲ +0.11SPCX1,507 mentions▲ +0.08NBIS1,432 mentions▲ +0.09HTZ1,239 mentions▲ +0.10NVDA1,220 mentions▲ +0.08META1,088 mentions▲ +0.03MSFT858 mentions▲ +0.06

Equity · Healthcare

CGEN

Compugen Ltd. · NasdaqCM

$2.50 +3.73% 1D Finazon · prior-day close · Aug 12, 2026
Price · Chart
Our own end-of-day closes 58 sessions
$3.0 $1.5 20 May 12 Aug

The line runs $2.70 on 20 May through $2.50 on 12 August, on a scale from $1.5 to $3.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of CGEN over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 58 sessions over that window: $2.70 on 20 May 2026 through $2.50 on 12 August 2026.

52-week range $1.33 – $3.11
Avg volume 71.7K

Finazon · prior-day close · as of Aug 18, 2026

Filings 3 sets

CGEN reported financials

SEC EDGAR XBRL

CGEN reported revenue of $72.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was $35.3M.

Figure Reported Period
Revenue $72.8M 31 Dec 2025 fiscal year
Net income $35.3M 31 Dec 2025 fiscal year
Diluted EPS $0.38 31 Dec 2025 fiscal year
Total assets $156.6M 31 Dec 2025 at period end
Total equity $102.7M 31 Dec 2025 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025

CGEN institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a CGEN position for the quarter ended 30 Jun 2026 — a combined $7.6M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) +15.0% shares 1,877,500 $4.0M
ARK Investment Management Trimmed −25.1% shares 786,536 $1.7M
Two Sigma Investments Held (±25%) −1.8% shares 512,419 $1.1M
Millennium Management Added +55.1% shares 262,032 $561K
Citadel Advisors Held (±25%) −7.9% shares 103,526 $222K
Marshall Wace Trimmed −92.0% shares 19,617 $42K
Point72 Asset Management New position 11,901 $25K

Source: SEC EDGAR 13F filings

CGEN fails-to-deliver

SEC CNS data

On 31 Jul 2026, 303 shares of CGEN failed to deliver (about $709).

Settlement date Shares failed Notional % of shares out
31 Jul 2026 303 $709 <0.001%
21 Jul 2026 176 $412 <0.001%
17 Jul 2026 52,627 $123K 0.056%
10 Jul 2026 1,126 $3K 0.001%
09 Jul 2026 470 $1K <0.001%
07 Jul 2026 1,754 $4K 0.002%
06 Jul 2026 2,241 $5K 0.002%

Source: SEC fails-to-deliver (CNS) data